United States Alzheimer's Disease Market and Competitive Landscape Highlights 2010-2020 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "US Alzheimer's Disease Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

US Alzheimer's Disease Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Alzheimer's Disease pipeline products, Alzheimer's Disease epidemiology, Alzheimer's Disease market valuations and forecast, Alzheimer's Disease products sales and competitive landscape in the US.

The research is classified into nine sections - Alzheimer's Disease overview including etiology, pathophysiology, and diagnosis, Alzheimer's Disease treatment options, Alzheimer's Disease pipeline products, Alzheimer's Disease market analysis comprising of Alzheimer's Disease epidemiology, key products marketed for Alzheimer's Disease, market valuations and forecast, products sales and market shares.

Research Scope:

  • Alzheimer's Disease Pipeline: Find out the products in clinical trials for the treatment of Alzheimer's Disease by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Alzheimer's Disease Epidemiology: Find out the number of patients diagnosed (prevalence) with Alzheimer's Disease in the US
  • Alzheimer's Disease Products: Identify key products marketed and prescribed for Alzheimer's Disease in the US, including trade name, molecule name, and company
  • Alzheimer's Disease Product Sales: Find out the sales revenues of Alzheimer's Disease products, both branded and generics, in the US
  • Alzheimer's Disease Market Valuations: Find out the market size for Alzheimer's Disease products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
  • Alzheimer's Disease Products Market Share: Find out the market shares for key Alzheimer's Disease products in the US

Key Topics Covered:

  1. Disease Overview
  2. Alzheimer's Disease Treatments
  3. Alzheimer's Disease Pipeline
  4. US Alzheimer's Disease Epidemiology
  5. Marketed Drugs for Alzheimer's Disease in US
  6. US Alzheimer's Disease Market Size
  7. US Alzheimer's Disease Products Sales
  8. US Alzheimer's Disease Market Competitive Landscape
  9. US Alzheimer's Disease Market Forecast

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/kzs3f9/us_alzheimers

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs , Alzheimer's Disease Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs , Alzheimer's Disease Drugs